Displaying drugs 8851 - 8875 of 9175 in total
Pritumumab
Investigational
Tamrintamab pamozirine
Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.
Investigational
STRO-001
Investigational
PRGN-3006
PRGN-3006 are autologous CD3+ T cells genetically modified using a non-viral system to express a CD33 CAR, membrane-bound interleukin-15, and a truncated form of human HER1T (kill switch) on the cell surface.
Investigational
JCAR014
Investigational
Letetresgene autoleucel
Investigational
Golnerminogene pradenovec
Investigational
M-032
Investigational
Zevorcabtagene autoleucel
Investigational
TNB-383B
TNB-383B is a CD3 and B-cell maturation antigen T-cell engaging bispecific antibody.
Investigational
Galinpepimut-S
Investigational
ST101 peptide
ST101 is a cell-penetrating peptide that disrupts the protein-protein interactions driving ATF5-regulated gene transcription.
Investigational
ONCOS-102
Investigational
GVAX
GVAX is a granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transfected tumor cell vaccine.
Investigational
OriCar-017
Investigational
Pelareorep
Investigational
G305
G305 is a recombinant NY-ESO-1 protein plus glucopyranosyl lipid A (GLA) in a stable emulsion (SE). G305 is an active component of CMB305 along with LV305.
Investigational
Pixofisiran
Investigational
Lixadesiran
Investigational
Tavokinogene telseplasmid
Tavokinogene telseplasmid consists of a DNA Plasmid Vector Encoding IL-12.
Investigational
Hepcortespenlisimut-L
Investigational
Leukocyte interleukin
Investigational
Displaying drugs 8851 - 8875 of 9175 in total